3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, Mantle-Cell
1
HER2-negative Breast Cancer
1
Behavior
1
Interventions
eribulin
3
Vinorelbine
2
Paclitaxel
2
Epirubicin
2
Doxorubicin
2
Cyclophosphamide
2
trastuzumab deruxtecan
1
tislelizumab
1
taxane
1
sacituzumab govitecan
1
pembrolizumab
1
pamiparib
1
liposomal doxorubicin
1
camrelizumab
1
anlotinib
1
Taxes
1
Precision Medicine
1
Gemcitabine
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Capecitabine
1
Anthracyclines
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HER2-negative Breast Cancer
×
Precision Medicine
×
Clear all
NCT04450706
2024-10-28
FORESEE
University of Utah
Phase NA
Completed
15 enrolled